Invention Grant
US08211857B2 Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
有权
通过抑制TRPV6钙通道活性来治疗癌症的肽组合物
- Patent Title: Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
- Patent Title (中): 通过抑制TRPV6钙通道活性来治疗癌症的肽组合物
-
Application No.: US12886397Application Date: 2010-09-20
-
Publication No.: US08211857B2Publication Date: 2012-07-03
- Inventor: John M. Stewart
- Applicant: John M. Stewart
- Applicant Address: CA Sackville, NB
- Assignee: Soricimed Biopharma Inc.
- Current Assignee: Soricimed Biopharma Inc.
- Current Assignee Address: CA Sackville, NB
- Agency: Bereskin & Parr LLP
- Agent Noel Courage
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K38/10 ; C07K14/47
Abstract:
The invention includes an isolated peptide comprising all or part of the amino acid sequence: EGKLSSNDTE GGLCKEFLHP SKVDLPR (SEQ ID NO: 1), wherein the peptide inhibits calcium channel activity. The peptides of the invention are useful for preventing or treating cancer.
Public/Granted literature
- US20110071089A1 PEPTIDE COMPOSITION FOR CANCER TREATMENT BY INHIBITING TRPV6 CALCIUM CHANNEL ACTIVITY Public/Granted day:2011-03-24
Information query
IPC分类:
